Allergy Expertise Target Bencard Allergie GmbH Deutschland und Österreich as a specialized partner in allergy therapeutics and diagnostics, offering collaboration on novel adjuvants, molecular allergen characterization, and perennial allergy management to expand their portfolio.

Research Momentum Leverage their ongoing R&D programs in Virus-like Particles adjuvants, Allergomics, and patient-friendly therapies to position joint development or licensing discussions around next‑generation allergy treatments and diagnostic solutions.

Global Backbone Capitalize on being a subsidiary of Allergy Therapeutics with access to international networks and capital, enabling co-development, regional market entries, or contract manufacturing partnerships to scale in Europe and beyond.

Diagnostics Diagnostic Propose integrated diagnostic and prick test solutions paired with therapeutic programs, aligning sales to their broad diagnostic portfolio and readiness for expanded testing services in both Germany and Austria.

Growth Signals Position offerings that support sustainable growth given their 85‑year heritage and positive earnings trajectory, focusing on scalable manufacturing, regulatory support, and commercial models that reduce time‑to‑market for new allergy products.